1 December 2024 false Taxfiler 2024.6 16104366 business:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 16104366 2024-11-30 16104366 2024-12-01 2025-11-30 16104366 business:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 16104366 business:FilletedAccounts 2024-12-01 2025-11-30 16104366 2025-11-30 16104366 business:Director1 2024-12-01 2025-11-30 16104366 business:RegisteredOffice 2024-12-01 2025-11-30 16104366 core:WithinOneYear 2025-11-30 16104366 core:ShareCapital core:PreviouslyStatedAmount 2025-11-30 16104366 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-11-30 16104366 core:PreviouslyStatedAmount 2025-11-30 16104366 business:SmallEntities 2024-12-01 2025-11-30 16104366 countries:EnglandWales 2024-12-01 2025-11-30 16104366 business:OrdinaryShareClass1 2024-12-01 2025-11-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 16104366 (England and Wales)
Panday Pharma Ltd Filleted accounts for the year ended 30 November 2025
Panday Pharma Ltd Filleted accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Panday Pharma Ltd Company Information for the year ended 30 November 2025
Director
Patrica Panday
Company Number
16104366 (England and Wales)
Registered Office
37 Prince Henry Road London SE7 8PP England
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
Panday Pharma Ltd Statement of financial position as at 30 November 2025
2025
Notes
£
Current assets
Cash at bank and in hand
40,000
Creditors: amounts falling due within one year
4
(9,046)
Net current assets
30,954
Net assets
30,954
Capital and reserves
Called up share capital
5
100
Profit and loss account
30,854
Shareholders' funds
30,954
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 26 July 2026 and were signed on its behalf by
Patrica Panday Director Company Registration No. 16104366
- 4 -
Panday Pharma Ltd Notes to the Accounts for the year ended 30 November 2025
1
Statutory information
Panday Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 16104366. The registered office is 37 Prince Henry Road, London, SE7 8PP, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
4
Creditors: amounts falling due within one year
2025
£
Taxes and social security
7,472
Loans from directors
914
Accruals
660
9,046
5
Share capital
2025
£
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
Shares issued during the period:
100 Ordinary shares of £1 each
100
- 5 -
Panday Pharma Ltd Notes to the Accounts for the year ended 30 November 2025
6
Average number of employees
During the year the average number of employees was 1.
- 6 -